AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 82 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $30,000 | -16.7% | 63,436 | 0.0% | 0.00% | – |
| Q4 2021 | $36,000 | -71.7% | 63,436 | -17.3% | 0.00% | – |
| Q3 2021 | $127,000 | -0.8% | 76,661 | 0.0% | 0.00% | – |
| Q2 2021 | $128,000 | +481.8% | 76,661 | +95.7% | 0.00% | – |
| Q1 2019 | $22,000 | +46.7% | 39,169 | 0.0% | 0.00% | – |
| Q4 2018 | $15,000 | -25.0% | 39,169 | 0.0% | 0.00% | – |
| Q3 2018 | $20,000 | -76.7% | 39,169 | 0.0% | 0.00% | – |
| Q2 2018 | $86,000 | +377.8% | 39,169 | +71.1% | 0.00% | – |
| Q1 2017 | $18,000 | -14.3% | 22,886 | 0.0% | 0.00% | – |
| Q4 2016 | $21,000 | +23.5% | 22,886 | 0.0% | 0.00% | – |
| Q3 2016 | $17,000 | -43.3% | 22,886 | 0.0% | 0.00% | – |
| Q2 2016 | $30,000 | -85.8% | 22,886 | -18.3% | 0.00% | – |
| Q1 2015 | $211,000 | +119.8% | 28,004 | 0.0% | 0.00% | – |
| Q4 2014 | $96,000 | -3.0% | 28,004 | 0.0% | 0.00% | – |
| Q3 2014 | $99,000 | -57.7% | 28,004 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $234,000 | – | 28,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,595,484 | $10,564,000 | 9.31% |
| Cypress Capital Management LLC (WY) | 108,400 | $441,000 | 0.50% |
| Noven Financial Group, Inc. | 158,059 | $643,000 | 0.37% |
| Transform Wealth, LLC | 205,481 | $836,000 | 0.15% |
| GHP Investment Advisors, Inc. | 100,000 | $407,000 | 0.06% |
| Pratt Collard Advisory Partners LLC | 15,600 | $63,000 | 0.05% |
| JANICZEK WEALTH MANAGEMENT, LLC | 16,719 | $68,000 | 0.04% |
| Virtu Financial LLC | 92,344 | $376,000 | 0.02% |
| JFS WEALTH ADVISORS, LLC | 18,150 | $74,000 | 0.02% |
| CONDOR CAPITAL MANAGEMENT | 21,400 | $87,000 | 0.02% |